RT @synovialjoints: What guides treatment decisions in AxSpA? Bolt et al showed patients assessed in clinical remission,
Tweet Content
What guides treatment decisions in AxSpA? Bolt et al showed patients assessed in clinical remission, 1/3 had BASDAI >3.5. Treatment unchanged as low disease activity, awaiting effects of current Rx, complaints not related to axSpA, patient preference #EULAR2022 @RheumNow POS0303
Show on Archive Page
On
Display in Search Results
On
PDQ
Off